Clinical translation of silica nanoparticles

Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Janjua, Taskeen Iqbal, Cao, Yuxue, Yu, Chengzhong, Popat, Amirali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496429/
https://www.ncbi.nlm.nih.gov/pubmed/34642607
http://dx.doi.org/10.1038/s41578-021-00385-x
_version_ 1784579757038370816
author Janjua, Taskeen Iqbal
Cao, Yuxue
Yu, Chengzhong
Popat, Amirali
author_facet Janjua, Taskeen Iqbal
Cao, Yuxue
Yu, Chengzhong
Popat, Amirali
author_sort Janjua, Taskeen Iqbal
collection PubMed
description Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.
format Online
Article
Text
id pubmed-8496429
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84964292021-10-08 Clinical translation of silica nanoparticles Janjua, Taskeen Iqbal Cao, Yuxue Yu, Chengzhong Popat, Amirali Nat Rev Mater Comment Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios. Nature Publishing Group UK 2021-10-07 2021 /pmc/articles/PMC8496429/ /pubmed/34642607 http://dx.doi.org/10.1038/s41578-021-00385-x Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Janjua, Taskeen Iqbal
Cao, Yuxue
Yu, Chengzhong
Popat, Amirali
Clinical translation of silica nanoparticles
title Clinical translation of silica nanoparticles
title_full Clinical translation of silica nanoparticles
title_fullStr Clinical translation of silica nanoparticles
title_full_unstemmed Clinical translation of silica nanoparticles
title_short Clinical translation of silica nanoparticles
title_sort clinical translation of silica nanoparticles
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496429/
https://www.ncbi.nlm.nih.gov/pubmed/34642607
http://dx.doi.org/10.1038/s41578-021-00385-x
work_keys_str_mv AT janjuataskeeniqbal clinicaltranslationofsilicananoparticles
AT caoyuxue clinicaltranslationofsilicananoparticles
AT yuchengzhong clinicaltranslationofsilicananoparticles
AT popatamirali clinicaltranslationofsilicananoparticles

Ejemplares similares